Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accord 08: Irinox vs FOLFIRI vs FOLFOX in First-Line Metastatic Colorectal Cancer
NCT00066274Phase 2Completed
- Sponsor
- Unicancer
- Start
- Jul 2002
- Primary completion
- Nov 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan, oxaliplatin in colorectal cancer (CRC), sponsored by Unicancer. Started Jul 2002; status: completed.
02
Drugs
irinotecanoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00066274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066274.